Indo Rama Synthetics (India) Limited has informed the Exchange regarding Board meeting held on May 13, 2025.
INDORAMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025. The company returned to profitability with standalone profit before tax of Rs. 20.08 crore versus a loss of Rs. 141.66 crore in FY24. Operating cash flow turned sharply positive at Rs. 335.86 crore standalone and Rs. 391.41 crore consolidated, compared to negative cash flow last year. The board did not declare any dividend for FY25. Statutory auditor Walker Chandiok & Co LLP resigned on May 13, 2025, after signing the FY25 accounts, and S S Kothari Mehta & Co LLP was appointed to fill the casual vacancy and for a five-year term subject to shareholder approval. Independent director Ranjana Agarwal's second term ends May 17, 2025, and board committees were reconstituted accordingly. The 39th AGM is scheduled for July 23, 2025.
Good news: clear turnaround in profits and strong cash generation signal improving operations and may lift sentiment. Bad news: standalone current liabilities exceed current assets by Rs. 612.49 crore and consolidated by Rs. 816.44 crore, the auditor flagged uncertainty around recoverability of Rs. 258.61 crore in deferred tax assets, and the sudden auditor change right after signing accounts may raise governance concerns. No dividend disappoints income-seeking shareholders; the stock may remain volatile given the mixed fundamentals.